Cytogen, Inc. Stock

A217330

KR7217330000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 30/09/2026			5-day change	1st Jan Change
3,040.00 ^KRW	+0.33%		+1.16%	-66.18%

05-18	Cytogen, Inc. announced that it expects to receive KRW 5.2 billion in funding from BNK Securities Co.,Ltd., Hanyang Securities Co. Ltd. and other investors.	CI
11-05	Cytogen wins 1 billion won order	RE

Cytogen Inc is a Korea-based company mainly engaged in the provision of liquid biopsy application services. The liquid biopsy application services include biomarker discovery and verification services, as well as liquid biopsy-based precision medical services which is the commercialization of companion diagnostics (CDx) development, among others. The biomarker discovery and verification services include circulating tumor cell (CTC)-based biomarker discovery and validation, gene mutation and transcript expression analysis, and drug testing and analysis services, among others. The liquid biopsy-based precision healthcare services include companion diagnosis, re-selection of therapeutic drugs, examination and treatment effectiveness monitoring, and recurrence prediction services, among others. In addition, the Company develops and sells platforms and kits for liquid biopsy. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
30/09/26	₩3,040.00	+0.33%	26,740
29/09/26	₩3,030.00	-4.87%	48,291
28/09/26	₩3,185.00	+5.29%	90,426
23/09/26	₩3,025.00	+0.67%	28,910
22/09/26	₩3,005.00	-1.96%	38,021

End-of-day quote Korea S.E.

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
A217330 Stock

As early as today, start finding the best investment opportunities!

Market Cap	70.31B 51.84M 45.75M 43.28M 39.25M 73.59M 4.97B 74.32M 519M 200M 2.54B 195M 190M 8.17B	P/E 2024	-5.98x	P/E 2025	-16.8x
Enterprise Value	55.07B 40.61M 35.83M 33.9M 30.75M 57.65M 3.9B 58.22M 407M 157M 1.99B 152M 149M 6.4B	EV / Sales 2024	7.17x	EV / Sales 2025	7.38x
Free-Float	58.21%	Yield 2024 *	-	Yield 2025	-

05-18	Cytogen, Inc. announced that it expects to receive KRW 5.2 billion in funding from BNK Securities Co.,Ltd., Hanyang Securities Co. Ltd. and other investors.	CI
11-05	Cytogen wins 1 billion won order	RE
10/09/25	Cytogen sells 160 million won worth of own shares	RE
02/01/25	Cytogen Moves to Dual CEO Arrangement	MT
23/09/24	Cytogen, Inc.(KOSDAQ:A217330) dropped from S&P Global BMI Index	CI
22/08/24	Cytogen, Inc. announced that it has received KRW 6.500000445 billion in funding from Theragen Etex Co.,Ltd.	CI
31/07/24	Cytogen, Inc. agreed to acquire 98.95% stake in Theragen Genomecare Co. Ltd from Theragen Etex Co.,Ltd. and Daeilgen Bio for KRW 13.2 billion.	CI
20/03/24	Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	CI
18/03/24	Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	CI
28/12/23	Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited	CI
28/12/23	Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited	CI
19/12/23	Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion	CI
27/10/23	Cytogen, Inc. announces tranche update	CI

1 day	+0.33%
1 week	+1.16%
Current month	-3.34%
1 month	-4.55%
3 months	-9.25%
6 months	-35.59%
Current year	-66.18%

1 week	3,010	3,230
1 month	2,940	3,230
Current year	2,760	11,200
1 year	2,450	11,200
3 years	2,260	16,700
5 years	2,260	23,066.67
10 years	2,260	24,166.67

Manager	Title	Age	Since
Ji-Hun Ahn CEO	Chief Executive Officer	45	02/01/2025
Byeong-Hui Jeon CEO	Chief Executive Officer	67	02/01/2025
Young-Woong Son PRN	Corporate Officer/Principal	52	31/03/2025

Cytogen, Inc. Stock

Stocks

A217330

KR7217330000

Biotechnology & Medical Research

Valuation: Cytogen, Inc.

Chart: Cytogen, Inc.

Latest news: Cytogen, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Cytogen, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Director	Title	Age	Since
Byeong-Hui Jeon BRD	Director/Board Member	67	02/01/2025
Nam-Ho Bang BRD	Director/Board Member	64	23/09/2024
Young-Woong Son BRD	Director/Board Member	52	31/03/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYTOGEN, INC.	+0.33%	+1.16%	+28.54%	-80.92%	51.67M
WUXI APPTEC CO., LTD.	+4.16%	-0.30%	+58.96%	+94.17%	71.53B
ARGENX SE	-0.19%	+1.32%	+37.20%	+81.33%	60.12B
LONZA GROUP AG	-1.51%	+2.39%	+9.10%	+36.79%	48.85B
IQVIA HOLDINGS INC.	+1.01%	+1.17%	+42.67%	+39.77%	44.28B
REVOLUTION MEDICINES, INC.	+2.01%	+9.13%	+345.72%	+695.38%	43.83B
BEONE MEDICINES AG	+2.11%	+2.23%	+9.52%	+109.04%	41.53B
CELLTRION, INC.	-0.67%	-0.45%	+4.47%	+46.37%	30.13B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.46%	+41.54%	+22.78%	27.98B
INSMED INCORPORATED	+0.17%	-2.40%	-19.80%	+355.26%	25.25B
Average	+1.26%	+0.55%	+55.79%	+140.00%	39.36B
Weighted average by Cap.	+1.45%	+0.63%	+63.86%	+155.48%

	2024	2025
Net sales	10.91B 8.04M 7.1M 6.72M 6.09M 11.42M 772M 11.53M 80.58M 31.06M 394M 30.21M 29.55M 1.27B	26.05B 19.21M 16.95M 16.04M 14.55M 27.27M 1.84B 27.54M 192M 74.16M 941M 72.13M 70.57M 3.03B
Net income	-17.12B -12.62M -11.14M -10.54M -9.56M -17.92M -1.21B -18.09M -126M -48.72M -618M -47.39M -46.36M -1.99B	-12.34B -9.1M -8.03M -7.6M -6.89M -12.92M -873M -13.05M -91.16M -35.13M -446M -34.17M -33.43M -1.43B
Net Debt	-26.39B -19.46M -17.17M -16.25M -14.74M -27.63M -1.87B -27.9M -195M -75.13M -954M -73.08M -71.49M -3.07B	-15.23B -11.23M -9.91M -9.38M -8.5M -15.95M -1.08B -16.1M -113M -43.36M -550M -42.17M -41.26M -1.77B